Viridian Therapeutics, Inc. (VRDN)
30.25
+0.87
(+2.96%)
USD |
NASDAQ |
Mar 02, 16:00
29.50
-0.75
(-2.48%)
After-Hours: 06:41
Viridian Therapeutics Research and Development Expense (TTM) : 338.47M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 14.74M |
| ADMA Biologics, Inc. | 4.761M |
| Avantor, Inc. | -- |
| Immunovant, Inc. | 408.02M |
| Plus Therapeutics, Inc. | 7.624M |